Accessibility Menu
 
Convey Health Solutions logo

Convey Health Solutions

(NYSE) CNVY

Current PriceN/A
Market CapN/A
Since IPO (2021)-19%
5 YearN/A
1 Year+32%
1 Month+0%

Convey Health Solutions Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$366.21M

Net Income (TTM)

$6.95M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

CNVY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Convey Health Solutions

Industry

Health Care Technology

Employees

3,800

CEO

Stephen C. Farrell, MBA, CPA

Headquarters

Fort Lauderdale, FL 33394, US

CNVY Financials

Key Financial Metrics (TTM)

Gross Margin

42%

Operating Margin

-8%

Net Income Margin

-3%

Return on Equity

-2%

Return on Capital

-4%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

-7.47%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$142.28M

Operating Income

$27.91M

EBITDA

$22.31M

Operating Cash Flow

$2.31M

Capital Expenditure

$12.33M

Free Cash Flow

$14.64M

Cash & ST Invst.

$38.81M

Total Debt

$528.00K

Convey Health Solutions Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2022YOY CHG

Revenue

$89.78M

+19.3%

Gross Profit

$30.48M

-5.2%

Gross Margin

33.94%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

2,960

N/A

Net Income

$9.89M

+24.8%

EBITDA

$628.00K

+115.3%

Quarterly Fundamentals

Name
Q2 2022YOY CHG

Net Cash

$271.92M

-60.7%

Accounts Receivable

$71.56M

+60.6%

Inventory

$38.57M

+192.5%

Long Term Debt

$284.38M

+49.5%

Short Term Debt

$7.25M

+1699.3%

Return on Assets

-1.20%

N/A

Return on Invested Capital

-3.67%

N/A

Free Cash Flow

$782.00K

+92.4%

Operating Cash Flow

$1.89M

+122.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ICVXIcosavax, Inc.
$15.31-0.91%
ACCDAccolade, Inc.
$7.02+0.00%
ASLNASLAN Pharmaceuticals Limited
$0.60-14.27%
ICPTIntercept Pharmaceuticals, Inc.
$19.00+0.21%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%
NOKNokia
$8.82+0.07%

Questions About CNVY

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.